Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Qiagen (QGEN) over the last 12 years, with Q4 2025 value amounting to $16.6 million.

  • Qiagen's Share-based Compensation rose 5317.52% to $16.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.4 million, marking a year-over-year increase of 1552.48%. This contributed to the annual value of $50.4 million for FY2025, which is 1552.48% up from last year.
  • Qiagen's Share-based Compensation amounted to $16.6 million in Q4 2025, which was up 5317.52% from $10.7 million recorded in Q3 2025.
  • Qiagen's Share-based Compensation's 5-year high stood at $16.6 million during Q4 2025, with a 5-year trough of $7.0 million in Q4 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $11.6 million (2022), whereas its average is $11.5 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 9592.54% in 2022, then crashed by 3223.06% in 2024.
  • Over the past 5 years, Qiagen's Share-based Compensation (Quarter) stood at $7.0 million in 2021, then surged by 95.93% to $13.7 million in 2022, then fell by 11.88% to $12.0 million in 2023, then dropped by 9.96% to $10.8 million in 2024, then skyrocketed by 53.18% to $16.6 million in 2025.
  • Its last three reported values are $16.6 million in Q4 2025, $10.7 million for Q3 2025, and $10.8 million during Q2 2025.